Knowing when to step up your Mounjaro dose, and, just as importantly, when not to, is one of the parts of treatment most people get wrong. Escalation is a clinical decision, not a calendar reminder.
The standard ladder
Mounjaro is titrated upward through six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg, with a minimum of four weeks at each step. 2.5mg is a tolerance-building starting dose, not a treatment dose.
| Dose | Typical minimum duration | Role |
|---|---|---|
| 2.5mg | 4 weeks | Starting dose, tolerance only |
| 5mg | 4 weeks minimum | First therapeutic dose |
| 7.5mg | 4 weeks minimum | Therapeutic |
| 10mg | 4 weeks minimum | Therapeutic, common maintenance |
| 12.5mg | 4 weeks minimum | Therapeutic |
| 15mg | Ongoing | Maximum dose |
Does a higher dose mean more weight loss?
On average, yes. In the SURMOUNT-1 trial (New England Journal of Medicine, 2022), 2,539 adults without diabetes lost an average of 15.0% of their body weight on tirzepatide 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% on placebo, counting everyone who started treatment. Among people who stayed on treatment, the averages were 16.0%, 21.4% and 22.5%. Individual results vary. But the increments get smaller as you climb, while side effects don't. The best dose is the lowest one achieving good progress with tolerable side effects.
When to step up
- You've completed at least four weeks at your current dose.
- Side effects have settled and are manageable.
- Weight loss has stalled meaningfully at an established dose.
- Appetite suppression is clearly fading well before your next injection.
When to hold
- You're still losing well. There is no prize for reaching 15mg.
- Side effects from the last increase haven't settled.
- You're dehydrated or not eating adequately.
- Life circumstances such as travel, illness or a demanding period make a rough week a bad idea.
Why rushing backfires
In the SURMOUNT-1 and SURMOUNT-2 trials, stomach and bowel side effects led 1.9% of people on tirzepatide 5mg, 3.3% on 10mg and 4.3% on 15mg to stop treatment, compared with 0.5% on placebo (Mounjaro UK product information). Individual results vary. Staying longer at a working dose is a legitimate clinical strategy, not a delay.
Maintenance
Many people settle below 15mg long-term. That's a success, not a shortfall. The goal is durable weight loss with tolerable side effects, not a personal best on the dosing chart.
The right dose isn't the highest one you can reach. It's the lowest one that keeps you losing weight steadily without making you miserable.
See also why am I not losing weight on Mounjaro, Mounjaro side effects and Mounjaro weight loss by week.